register free | resend password


Adastra Announces Fulfillment of Distillate & Vape Cart Purchase Orders

ID: 1560074
recent pressrelease next pressrelease

(businesspress24) - LANGLEY, BC / August 12, 2020 - Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (Adastra) a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the fulfillment of its purchase order for bulk distillate and an order for 30,000 vaporizing cartridges from CannMart Inc. (CannMart) a majority owned subsidiary of Namaste Technologies Inc. (Namaste) (TSX-V: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF).

Adastras CO2 extraction process line was used to fulfill this bulk distillate order that will be used in CannMarts licensed formulations for vaporizing cartridges, disposable vaporizers and vaporizing kits for its concentrate SKUs. This CO2 extraction line has a capacity of over 90 KGs of high-grade distillate a week, representing a 0.5 gram vaporizing cartridge capacity of 180,000. This CO2 production line will be soon repurposed to manufacture other higher margin, niche CO2-derived extract products (e.g. High Terpene Full Spectrum Extracts/Terp sauce) when an additional higher-capacity cryo-ethanol extraction line is installed and commissioned , which is expected to be completed within a month .
https://www.irw-press.at/prcom/images/messages/2020/52996/Press Release - 2020-08-12 - Distillate Vape Cart Fulfillment - v0.2_PRcom.001.jpeg

Figure 1 - High-grade Cannabis Distillate Produced by Adastra

Adastra validated its formulating and filling procedures while honing its quality and process control measures to ensure the highest quality products for its client CannMart. These two vape cartridge formulation runs formed the basis of Adastras Health Canada sales licence submission package earlier this month. Currently, Adastra can provide B2B client white labeling services for multiple distillate-related products including bulk distillate, tinctures, vape, beverage and edible formulations.


Figure 2 - Adastra filled vaporizing cartridges and shipment to client


"We are pleased to announce the fulfilment of CannMarts purchase order. Additionally, we have completed fulfillment our first large vape cartridge order with a client. This run of two new flavours for the CannMart licensed Phyto Extractions vape cart line will add to their offerings across Canada. These along with other purchase orders will help Adastra support CannMarts line of branded concentrate products that are selling throughout most Canadian provinces. - Andy Hale, CEO

About Adastra Labs Holdings Ltd.

Adastra Labs Holdings Ltd. is a Langley, BC-based cannabis company with a co-located Health Canada Licensed Standard Processing Facility and Analytical Testing Laboratory. Adastra can produce cannabis extract through supercritical CO2 extraction and secondary distillation as well as conduct in-process quality testing. Such extracts can easily be incorporated into edibles, beverages, topicals, tinctures, vape cartridges and other products that will serve the Canadian medical and adult-use cannabis markets.

www.adastralabs.ca

About Namaste Technologies Inc.

With headquarters in Toronto, ON, and offices in both B.C. and around the globe, Namaste Technologies is a leading online platform for cannabis products, accessories, and responsible education. The companys everything cannabis store, CannMart.com, provides customers with a diverse selection of hand-picked products from a multitude of federally licensed cultivators, all on one convenient site. Namastes global technology and continuous innovation address local needs in a burgeoning cannabis industry requiring smart solutions. Information on the Company and its many products can be accessed through the links below:

NamasteTechnologies.com
NamasteMD.com
Cannmart.com
NamasteVapes.ca
Everyonedoesit.ca

Andrew Hale
Chief Executive Officer
Adastra Labs Holdings Ltd.
Phone: (778) 715-5011
Email: andy(at)adastralabs.ca

Stephen Brohman
Chief Financial Officer
Adastra Labs Holdings Ltd.
Phone: (778) 715-5011
Email: steve(at)adastralabs.ca

Address:-5451 275 Street, Langley, BC V4W 3X8
Telephone:-778-715-5011
Fax:-844-874-9893

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION:

Except for statements of historic fact, this news release contains certain forward-looking information within the meaning of applicable securities law including statements relating to repurposing production lines, acquisition of equipment, expected product quality and margins, capabilities to provide white label products. Forward-looking information is frequently characterized by words such as plan, expect, project, intend, believe, anticipate, estimate and other similar words, or statements that certain events or conditions may or will occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE and Health Canada, economic, business, competitive, political and social uncertainties, failure to acquire and commission equipment, unexpected contamination of products, saturation of the market for the Companys current and proposed future product offerings, termination of expected supply agreements and loss of key personnel. There are uncertainties inherent in forward-looking information, including factors beyond the Companys control. There are no assurances that the business plans for the Company as described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or managements estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Companys filings with Canadian securities regulators, which are available at www.sedar.com.



More information:
http://



Keywords (optional):



Company information / Profile:

PressRelease by

Requests:





PressContact / Agency:



published by: irw
print pressrelease  send to a friend  

Date: 08/12/2020 - 22:01
Language: English
News-ID 1560074
Character count: 6503
Kontakt-Informationen:
Firma: Adastra Labs Holdings Ltd.
Ansprechpartner: Feedback to businesspress24.com about Pressrelease-id:
Stadt: Wien
Telefon:

Meldungsart:
Versandart:
Freigabedatum:
Comments:



Number of hits: 284

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 64


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.